Demant A/S (WILYY) Stock Forecast, Price & News

Demant A/S (OTCMKTS:WILYY) Frequently Asked Questions

Is Demant A/S a buy right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Demant A/S in the last year. There are currently 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Demant A/S stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in WILYY, but not buy additional shares or sell existing shares.
View analyst ratings for Demant A/S or view top-rated stocks.

Are investors shorting Demant A/S?

Demant A/S saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 2,700 shares, an increase of 170.0% from the April 30th total of 1,000 shares. Based on an average daily volume of 1,100 shares, the short-interest ratio is presently 2.5 days.
View Demant A/S's Short Interest.

Who are Demant A/S's key executives?

Demant A/S's management team includes the following people:

• Mr. Søren Nielsen, CEO, Pres & Member of Exec. Board (Age 52, Pay $1.83M)
• Mr. René Schneider M.Sc, CFO & Member of Exec. Board (Age 49, Pay $806.7k)
• Mr. Niels Wagner, Pres of Hearing Care, Member of Exec. Board & Director (Age 51)
• Mr. Arne Boye Nielsen M.B.A., Pres of Diagnostics and Communications & Member of Exec. Board (Age 54)
• Mr. Mathias Holten Møller, Head of Investor Relations
• Ms. Trine Kromann-Mikkelsen, VP of Corp. Communication & Relations
• Mr. Finn Mohring, Sr. VP of R&D

Who are some of Demant A/S's key competitors?

Some companies that are related to Demant A/S include Coloplast A/S (CLPBY), Zimmer Biomet (ZBH), STERIS (STE), Align Technology (ALGN), Smith & Nephew (SNN), MSA Safety (MSA), Wound Management Technologies (WNDM), Shandong Weigao Group Medical Polymer (SHWGF), Enovis (ENOV), Establishment Labs (ESTA), Avanos Medical (AVNS), Cadre (CDRE), Inogen (INGN), Vicarious Surgical (RBOT) and Sanara MedTech (SMTI).
View all of WILYY's competitors.

What is Demant A/S's stock symbol?

Demant A/S trades on the OTCMKTS under the ticker symbol "WILYY."

How do I buy shares of Demant A/S?

Shares of WILYY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Demant A/S's stock price today?

One share of WILYY stock can currently be purchased for approximately $20.58.

How much money does Demant A/S make?

Demant A/S has a market capitalization of $9.48 billion and generates $2.22 billion in revenue each year.

How many employees does Demant A/S have?

Demant A/S employs 16,591 workers across the globe.

What is Demant A/S's official website?

The official website for Demant A/S is www.demant.com.

How can I contact Demant A/S?

Demant A/S's mailing address is Kongebakken 9, Smorum G7, 2765. The company can be reached via phone at (453) 917-7300, via email at [email protected], or via fax at 45-3927-8900.